Volume 93, Issue S255
ABS15-0703
Free Access

Dexamethasone induced glaucoma as part of chemotherapy for T cell lymphoblastic lymphoma

A.J. Lockwood

A.J. Lockwood

Ophthalmology, Southampton General Hospital, Southampton, United Kingdom

Ophthalmology, Queen Alexandra Hospital, Portsmouth, United Kingdom

Search for more papers by this author
A. Mitchell

A. Mitchell

Oncology, Southampton General Hospital, Southampton, United Kingdom

Search for more papers by this author
J. Gray

J. Gray

Oncology, Southampton General Hospital, Southampton, United Kingdom

Search for more papers by this author
K. May

K. May

Ophthalmology, Southampton General Hospital, Southampton, United Kingdom

Search for more papers by this author
First published: 23 September 2015
Citations: 1

Abstract

Purpose

To describe glaucoma after high dose corticosteroid chemotherapy in an 11-year-old girl.

Methods

Topical steroids are well known to induce a rise in intraocular pressure, but responses to oral steroids are rare. We report a significant elevation in an 11-year-old girl following high dose dexamethasone treatment as part of her chemotherapy for T cell lymphoblastic lymphoma.

Results

Six days after initiation of her first cycle of chemotherapy including oral dexamethasone 4.5 mg bd she presented with headaches, photophobia and blurring of vision. Intraocular pressures IOP were 48 and 52 mm Hg in the right and left eye respectively. Control of IOP was achieved medically, although systemic carbonic anhydrase inhibitor use necessitated admission to intensive care for renal support.

Conclusions

Vision threatening IOP rise may be a complication of high dose oral dexamethasone treatment. Routine screening of children undergoing this type of chemotherapy may be indicated.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.